MYM Nutraceuticals Inc.

Developing High-Quality CBD Nutraceuticals for the Global Marijuana Market

This profile is part of a paid investor education campaign.*


MYM Nutraceuticals Inc. (CSE:MYM) is an emerging cannabis grower and nutraceuticals manufacturing and distribution company focused on global cannabis markets. The company’s aggressive strategy for success is based on a commitment to superior growing technology, well-crafted branding and innovative distribution strategies.

This strategy coupled with strategic partners and sales revenue from multiple brands places MYM Nutraceuticals squarely on the path to becoming a fully-integrated cannabis company.

Through its subsidiary, Sublime Culture Inc., MYM Nutraceuticals is in the last stages of obtaining License Producer status under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR),and anticipates completing the first harvest at its Quebec-based operation in Q1 2019.

Over the course of 2018, MYM has expanded its operations in both Quebec, Canada and Australia. In Quebec, the company has completed construction on the first phase of its 36,000-square-foot facility in Laval, Quebec and is currently well underway on the construction of its 1.5 million-square-foot greenhouse facility in Weedon, Quebec.

In Australia, MYM has partnered with Solaris Nutraceuticals on the development of a 1.2 million-square-foot cultivation facility in the northern region of New South Wales.

MYM Nutraceuticals’ is in active discussions related to further acquisitions of complimentary businesses and assets in the technology, nutraceuticals and CBD sectors to build a strong presence within the cannabis industry. The company is led by an experienced management team with a track record of successful startups and expertise in navigating emerging markets. The Quebec-based cannabis production team has more than 30 years of growing experience and the skills to produce high-quality cannabis products.

Company Highlights

  • Phase 1 of Laval facility completed.
  • Construction is underway on its 1.5 million-square-foot facility in Weedon, Quebec
  • Partnered with PUF Ventures for build of 1.2 million-square-foot facility in New South Wales, Australia
  • Established medical client base with access to 3,000 patients
  • Strategic Partnerships with TheraCann Canada; Mohawk indigenous communities.
  • Building strong brand recognition and robust network of global distribution channels.
  • Solid management team with more than over 40 years of medical marijuana experience that is unmatched in the industry.

Quebec Production Facilities

Sublime Culture is the production wing of MYM Nutraceuticals and is a late-stage applicant to Health Canada’s ACMPR with a 36,000-square foot grow facility located in near Montreal in the city of Laval, Quebec. At build out, the facility is expected to produce approximately 3,000 kilograms of cannabis flower, generating an estimate annual revenue of $25 million.

Phase 2 of development expansion will include a roof-top greenhouse and a state-of-the-art extraction and processing department. The company intends to produce high-quality CBD products as well as Indica and Sativa cannabis strains.

MYM’s subsidiary, CannaCanada Inc, has also partnered with the City of Weedon, in Quebec on the Weedon project, construction is underway on the 1.5 million-square-foot greenhouse facility. Expected to be one of the largest production facilities in the world, the greenhouse has been approved by the municipal government and a license application is pending with Health Canada.

By full capacity in 2020, the company expects to produce up to 150,000 kilograms of cannabis per year. “MYM is working to open up cannabis distribution channels globally to accelerate our growth,” said MYM CEO Rob Gietl. “Our Weedon project alone has 329 acres to expand production. As recreational cannabis opens in more markets and as global markets expand, we plan on being ahead of the curve and have supply chains ready.”

MYM Australia

Expanding their international reach, MYM has also entered into a partnership with Solaris Nutraceuticals Inc. for the construction of a 1.2 million square-foot greenhouse facility in New South Wales, Australia. The project, named Northern Rivers, is a partnership with the Richmond Valley Council and will see the construction of a large-scale, manufacturing, processing and office facilities focused on cultivation, production and manufacturing of medical cannabis. MYM owns 35 percent of the project and the company plans to cover 300,000 square feet in the first phase of construction. At full scale, the facility will have the capacity to support annual production of 100,000 kilograms of high-quality cannabis.

Solaris Nutraceuticals Inc. has recently applied to the Australian Office of Drug Control for a medical cannabis license and a cannabis research license in collaboration with the National Institute of Complimentary Medicine (NICM). The company plans to conduct medical research at their Australian cultivation facility.


Rob Gietl—CEO

Rob Gietl is well known for his ability to exponentially grow businesses including the west-coast franchise expansion of Domino’s Pizza, where he consistently grew the annual business to achieve 300+% increases year-over-year. Mr. Gietl is a seasoned Business Development and Operations executive with a diverse track record of leading change across all areas of concept creation, brand re-positioning, market penetration, fiscal accountability and efficient execution of business plans. He has grown business effectiveness in an array of sectors and circumstances throughout Canada, consistently aligned with stakeholders’ goals and values.

Erick Factor—Executive Chairman

Erick Factor is a well-known expert in the MMJ industry and has 20 years of experience in cultivating medical marijuana and manufacturing cannabis by-products, and has provided medical marijuana to thousands of patients over the past two decades. He has extensive experience working with Health Canada, from whom he has obtained MMAR and MMPR licenses for hundreds of patients, and has managed and operated grow facilities to produce for those patients. Mr. Factor has also gained invaluable experience over the past three years in ACMPR licensing regulations and applications.

Howard Steinberg—Vice-Chairman & Independent Director

Mr. Steinberg has more than 20 years investment experience as a senior executive, working within some of the largest financial institutions in the world. He has sat on over a dozen Boards including his current role as Executive Chairman of Parallax Developments Corp. He has invested personally and with global financial institutions in a wide range of industries in every area of the balance sheet. Mr. Steinberg has an MBA from the University of Western Ontario and is a CFA charterholder.

Craig Lennox—CFO

Craig Lennox is a proven leader with an extensive background in financial management and operations. Mr. Lennox was most recently CFO at Clearly, a leading online optical retailer. He is a Chartered Professional Accountant and holds a Bachelor of Commerce degree from Queen’s University. He worked at Ernst & Young LLP in Toronto and Vancouver serving both public and private companies. Mr. Lennox spent over 5 years at The Jim Pattison Group Corporate Office in various senior financial roles. Mr. Lennox joined Clearly (Coastal Contacts Inc. – TSX listed) in 2012 as Vice-President of Finance where he was involved in building the business, listing the Company on the Nasdaq and in the ultimate sale of the company in April 2014 to Essilor for $430m. Mr. Lennox became Chief Financial Officer at Clearly in April 2014 and held that role until joining MYM.

Robin Linden—Independent Director

Mr. Linden has over 20 years leadership and management experience. He is currently a Director with Fairmont Hotels and Resorts based out of Vancouver, BC. Prior to that, Mr. Linden served in leadership and management roles with the University of Manitoba, Molson Breweries Canada and Canadian luxury retailer, Holt Renfrew. Mr. Linden holds a BA (hons) from the University of Manitoba and Post Graduate Diplomas from Simon Fraser University in Vancouver and the University of St. Andrews in Scotland.

Edward Tabisz—Independent Director

Mr. Tabisz is an Executive with TD Bank with over 15 years experience in Retail Distribution, Product Management, Finance and Operations. Mr. Tabisz currently leads the Finance team supporting the Real Estate Secured Lending business. Prior to, as an executive with TD Insurance, he led the strategic development and change management of their Life and Health product suite, the culmination of which resulted in an industry Six Sigma process improvement award. Mr. Tabisz graduated from the University of Manitoba in 2001 with more recent on- going continuous learning through Schulich School of Business, York University Executive Education Centre. Mr. Tabisz joins MYM’s board of directors effective May 1, 2018.

Elizabeth Liu—Independent Director

Ms. Elizabeth Liu founded and is Managing Director of LINK Business Law Group, a law firm that provides a broad range of legal, strategic and risk management advice, as well as general counsel services. Her clients include both early-stage and established companies in a variety of industries.Prior to establishing LINK Business Law Group, Ms. Liu was Managing Partner at Basham Thompson & Liu LLP, a boutique litigation firm. She then served as Vice President and General Counsel to the Flora Group of Companies where she was involved in all aspects of the group’s operations and provided guidance on contracts and other legal and risk planning issues. Flora manufactures and sells premium natural health products and has numerous distributorships in international markets. Ms. Liu was appointed Queen’s Counsel by Order-in- Council in December 2016.

Joel Lalancette—Master Grower

Mr. Lalancette brings with him thirteen years of experience in the greenhouse industry. He is an integrated operator who has been a leader in establishing numerous greenhouse businesses. His most recent experience saw him establish himself as one of Quebec’s largest producers of microgreens. Mr. Lalancette has vast knowledge and experience in large-scale greenhouse projects and is an expert in multi-zone, computer-controlled climate systems, hydroponic, aeroponic, and traditional soil systems.

Fabian Garcia—Weedon Project Manager

Mr. Garcia brings with him 15 years of experience in the oil and gas and petrochemical industry. He has served in a number of senior roles including Area Manager, Operations Manager, and General Manager. Mr. Garcia has a strong background in strategic planning, operations, restructuring, business development, and project start-ups. He has lived and worked in China, Qatar, Iraq, UAE, United States, Italy and Canada. He has a degree in Business Administration Marketing from Bishop’s University. Mr. Garcia will be responsible for the planning and build out of the Weedon project effective immediately.

*Disclaimer: The profile provides information which was sourced and approved by MYM Nutraceuticals Inc. in order to help investors learn more about the company. MYM Nutraceuticals Inc. is a client of the Investing News Network (INN). The company’s campaign fees pay for INN to create and update this profile page, to which links are placed on and channel newsletters.
The company description, investment highlights and catalysts were sourced by INN and approved by the company. INN does not guarantee the accuracy or thoroughness of the information contained on this page.
INN does not provide investment advice and the information on profile should not be considered a recommendation to buy or sell any security.
INN does not endorse or recommend the business, products, services or securities of any company profiled.
Readers should conduct their own research for all information publicly available concerning the company.